HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?
Muir
Andrew J
AJ
Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27710, USA. muir0002@mc.duke.edu